Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 21;82(9):769-773.
doi: 10.1093/jnen/nlad051.

Survival in sporadic ALS is associated with lower p62 burden in the spinal cord

Affiliations

Survival in sporadic ALS is associated with lower p62 burden in the spinal cord

Monica Pinkerton et al. J Neuropathol Exp Neurol. .

Abstract

The autophagy marker p62 appears as a consistent component of pathological aggregates in amyotrophic lateral sclerosis (ALS) and its modulation to facilitate protein degradation has been proposed as a potential therapeutic target. Importantly, recent studies have implicated diffuse phosphorylated TDP-43 inclusions that are immuno-negative for p62 in more rapid disease, highlighting the need for better understanding of p62 involvement in ALS pathogenesis. The present study set out to assess p62 pathology in the motor neurons of 31 patients with sporadic ALS that had either a short (<2 years) or longer (4-7 years) disease duration to determine its association with pTDP-43 pathology, motor neuron loss, and survival in sporadic disease. Our results identified significantly more cytoplasmic p62 aggregates in the spinal cord of patients with a shorter survival. Disease duration demonstrated a negative association with p62 burden and density of remaining motor neurons in the spinal cord, suggesting that survival in sporadic ALS is associated with the successful clearance of lower motor neurons with p62 aggregates. These findings implicate the autophagy pathway in ALS survival and provide support for further study of p62 as a potential prognostic biomarker in ALS.

Keywords: Amyotrophic lateral sclerosis; Motor neurons; p62 pathology; pTDP-43.

PubMed Disclaimer

Conflict of interest statement

The authors have no duality or conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Density (mean ± SE) of motor neurons in the spinal cord (A) and density of motor neurons with cytoplasmic p62-immunoreactive aggregates in the spinal cord (B–E) of ALS cases with a short (<2 years) or longer (4–7 years) disease duration. A significant positive association was identified between the density of p62 aggregates and surviving motor neurons (MNs) in the spinal cord (F). Increasing disease duration was associated with decreasing density of p62 aggregates (G) and surviving motor neurons in the spinal cord (H). SLI, skein-like inclusions. *p < 0.05; **p < 0.005.
Figure 2.
Figure 2.
Morphology of cytoplasmic p62-immunoreactive inclusions in the lower motor neurons. (A, C) Skein-like inclusions (B), dense round inclusion, and (D) dot-like inclusions.

Similar articles

Cited by

References

    1. Tan RH, Ke YD, Ittner LM, et al. ALS/FTLD: Experimental models and reality. Acta Neuropathol 2017;133:177–96 - PubMed
    1. Foster AD, Rea SL. The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen Res 2020;15:2186–94 - PMC - PubMed
    1. Davidson JM, Chung RS, Lee A. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Neurobiol Dis 2022;166:105653. - PubMed
    1. Burrell JR, Halliday GM, Kril JJ, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet 2016;388:919–31 - PubMed
    1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942–55 - PubMed

Publication types

MeSH terms

Supplementary concepts